Pantarhei Bioscience is a limited liability company located in Zeist, The Netherlands and was founded in January 2001.

Pantarhei has developed a sustainable product pipeline in the fields of Women’s Health and Endocrine Oncology based on its unique ability to identify novel medical uses for existing compounds including hormones and other endogenous human biologicals and/or (combinations of) existing drugs.

Pantarhei Bioscience announces discovery of antigen (ZP3) as a treatment to combat ovarian cancer. read more